Cue Biopharma, Inc. (NASDAQ:CUE) Q4 2020 Earnings Conference Call March 16, 2021 4:30 PM ET Company Participants George Zavoico - VP, IR & Corporate Development Daniel Passeri - CEO & Director Kenneth Pienta - Acting Chief Medical Officer Matteo Levisetti - SVP, Clinical Development Anish Suri - President & Chief Scientific Officer Kerri-Ann Millar - VP, Finance, Principal Finance & Accounting Officer Conference Call Participants Stephen Willey - Stifel, Nicolaus & Company Reni Benjamin - JMP Securities Kal ...

Corporate Presentation Immune Responses, On Cue™ Nasdaq: CUE | November 2020 | O P H A R M A y Forward-Looking Statements Disclaimer This presentation has been prepared by Cue Biopharma, Inc. ("we," "us," "our," "Cue" or the "Company") and is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities, nor shall there be any sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior t ...

Cue Biopharma, Inc. (NASDAQ:CUE) Q2 2020 Results Earnings Conference Call August 31, 2020 4:30 PM ET Company Participants George Zavoico - Vice President, Investor Relations & Corporate Development Dan Passeri - President and Chief Executive Officer Anish Suri - Chief Scientific Officer Ken Pienta - Acting Chief Medical Officer Kerri-Ann Millar - VP of Finance and Principal Accounting and Finance Officer Conference Call Participants Stephen Willey - Stifel Madhu Kumar - Baird Thomas Shrader - BTIG Reni Benj ...

Cue Biopharma, Inc. (NASDAQ:CUE) CEO Dan Passeri Q1 2020 Earnings Conference Call May 19, 2020 4:30 PM ET Company Participants Ashley Robinson - LifeSci Advisors Dan Passeri - President and Chief Executive Officer Anish Suri - Chief Scientific Officer Ken Pienta - Acting Chief Medical Officer Kerri-Ann Millar - VP of Finance and Principal Accounting and Finance Officer Conference Call Participants Boris Peaker - Cowen Stephen Willey - Stifel Mark Breidenbach - Oppenheimer Madhu Kumar - Robert W. Baird Reni ...

Cue Biopharma, Inc. (NASDAQ:CUE) Q4 2019 Earnings Conference Call March 17, 2020 4:30 PM ET Company Participants Ashley Robinson - IR Dan Passeri - President and CEO Anish Suri - Chief Scientific Officer Ken Pienta - Chief Medical Officer Kerri-Ann Millar - VP of Finance and Principal Accounting and Finance Officer Conference Call Participants Stephen Willey - Stifel Boris Peaker - Cowen and Company Mark Breidenbach - Oppenheimer & Co. Reni Benjamin - JMP Securities Madhu Kumar - Baird Operator Greeting and ...

Corporate Presentation BIO CEO & Investor Conference Immune Responses, On Cue™ Nasdaq: CUE February 12, 2019 Copyright © 2019. Cue Biopharma Forward-Looking Statements This presentation has been prepared by Cue Biopharma, Inc. ("we," "us," "our," "Cue" or the "Company") and is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities, nor shall there be any sale of any securities in any state or jurisdiction in which such offer, solicitatio ...